Orchestra BioMed Holdings (OBIO) FCF Margin (QoQ) (2022 - 2026)
Orchestra BioMed Holdings (OBIO) FCF Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Orchestra BioMed Holdings | 265.06 Mn | 80.63 Mn | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -193,682.00 |
| Mar 31, 2026 | -2.03 Mn |
| Dec 31, 2025 | 167,484.00 |
| Sep 30, 2025 | 17,890.00 |
| Jun 30, 2025 | 6,583.00 |
| Mar 31, 2025 | 346,570.00 |
| Dec 31, 2024 | -399,795.00 |
| Sep 30, 2024 | -6,936.00 |
| Jun 30, 2024 | 79,087.00 |
| Mar 31, 2024 | 207,095.00 |
| Dec 31, 2023 | -172,893.00 |
| Sep 30, 2023 | -130,907.00 |
| Jun 30, 2023 | 8,909.00 |
| Mar 31, 2023 | -44,085.00 |
| Dec 31, 2022 | -15,448.00 |
| Sep 30, 2022 | 140,945.00 |
| Jun 30, 2022 | -143,241.00 |